Scientific Discoveries | Novartis

Press Release
Oct 02, 2023

Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and highly statistically significant proteinuria reduction in patients with IgA nephropathy (IgAN)
Story
May 30, 2023

The future of medicine is here
Press Release
Oct 24, 2022

Novartis investigational oral monotherapy iptacopan demonstrates clinically meaningful superiority over anti-C5 treatment in Phase III APPLY-PNH study
Press Release
Dec 17, 2020

Novartis builds on commitment to addressing need in neuropsychiatric disorders with Cadent Therapeutics acquisition
Story
Mar 02, 2021

Take a visual tour of medicines that target RNA
Story
Nov 04, 2020

Need for new heart disease medicines drives wave of potential therapies
Story
Jun 01, 2017

Minion challenges assumptions about the genome
Story
Nov 04, 2015

Giraffes have high blood pressure. Why don’t they drop dead?
Story
Apr 13, 2015

Cancer spies find drug-beating covert cells
Story
May 20, 2016

Building brain organoids to shed light on disease
Story
Feb 11, 2016

Intractable tumor cells crippled
Story
Apr 18, 2016

Factory foreman keeps liver’s line workers on task